🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/05/2021 66,71 67,50 65,16 66,38 +1,10% 3,51% 641.700
06/05/2021 65,50 66,04 61,91 65,66 -1,22% 6,31% 915.600
05/05/2021 66,06 68,65 65,19 66,47 -0,02% 5,24% 930.500
04/05/2021 68,04 70,06 66,13 66,48 -5,35% 5,78% 835.900
03/05/2021 73,00 73,98 70,21 70,24 -3,46% 5,16% 559.600
30/04/2021 75,00 77,28 71,97 72,76 -3,96% 7,08% 926.700
29/04/2021 77,12 77,12 73,47 75,76 -0,26% 4,73% 607.400
28/04/2021 74,53 76,71 74,52 75,96 +1,93% 2,94% 721.600
27/04/2021 75,00 75,41 73,66 74,52 +0,03% 2,33% 663.500
26/04/2021 72,00 74,93 71,59 74,50 +4,06% 4,64% 653.900
23/04/2021 71,58 72,35 70,50 71,59 +0,85% 2,59% 559.000
22/04/2021 69,60 72,15 68,42 70,99 +2,84% 5,36% 712.600
21/04/2021 67,84 69,24 66,68 69,03 +1,34% 3,77% 554.600
20/04/2021 66,91 68,86 65,43 68,12 +1,67% 5,13% 466.600
19/04/2021 66,49 68,45 65,91 67,00 -0,96% 3,82% 538.000
16/04/2021 68,49 69,47 67,23 67,65 -0,49% 3,27% 636.200
15/04/2021 69,65 69,70 66,24 67,98 +1,21% 4,97% 720.700
14/04/2021 64,57 68,22 64,45 67,17 +5,07% 5,84% 648.700
13/04/2021 63,65 64,70 62,12 63,93 +1,83% 4,05% 406.900
12/04/2021 62,01 62,90 60,52 62,78 +1,01% 3,84% 493.400
09/04/2021 63,20 63,25 61,29 62,15 -2,45% 3,10% 783.300
08/04/2021 64,96 65,74 63,40 63,71 +0,50% 3,60% 399.100
07/04/2021 64,79 65,45 63,16 63,39 -2,70% 3,53% 526.900
06/04/2021 66,00 67,56 65,03 65,15 -3,08% 3,83% 414.400
05/04/2021 68,41 69,11 65,87 67,22 +0,22% 4,74% 461.500
01/04/2021 67,23 69,50 66,41 67,07 +1,15% 4,60% 530.800
31/03/2021 64,50 69,39 64,36 66,31 +4,11% 7,80% 982.400
30/03/2021 61,58 64,41 60,64 63,69 +3,81% 6,12% 638.800
29/03/2021 62,57 64,03 60,66 61,35 -2,54% 5,39% 700.900
26/03/2021 65,46 65,71 61,32 62,95 -3,47% 6,71% 883.900